PHARMACY

MinuteClinic opens first locations in New Mexico

BY Antoinette Alexander

WOONSOCKET, R.I. — MinuteClinic has opened New Mexico's first retail medical clinics inside three CVS/pharmacy stores in Albuquerque and one in Rio Rancho.

"We are excited to bring MinuteClinic's high quality, convenient and affordable medical services to New Mexico, our fourth expansion state in 2014," said Andrew Sussman, MinuteClinic president and CVS Health SVP/associate chief medical officer. "We anticipate an increasing demand for services in New Mexico, and believe MinuteClinic can be part of the solution to help broaden access to care for local residents."

Sussman stressed that MinuteClinic is committed to helping patients find a medical home and believes it can play a complementary role in working with primary care providers.

"About 50% of our visits occur on evenings, weekends and holidays when patients may not be able to get an appointment with their primary care provider," Sussman said. "And about half of the patients we see at MinuteClinic are 'medically homeless' and do not have a personal physician."

Patients who visit MinuteClinic without a PCP are provided a list of physicians in the area who are accepting new patients.

"MinuteClinic also has affiliations with 47 major health systems around the country, with joint clinical programs and integration of electronic medical records," Sussman added.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

FDA requests comments on ‘first generic’ ANDA submissions

BY Michael Johnsen

SILVER SPRING, Md. — The Food and Drug Administration on Wednesday opened a public docket and requested comments on proposed criteria for “first generic” abbreviated new drug application submissions.
 
According to the agency, establishing clear criteria for this review prioritization category will allow FDA to appropriately prioritize ANDA submissions and track them in a manner consistent with the review prioritization commitments FDA made pursuant to Generic Drug User Fee Amendments of 2012. Clear criteria for this category will also lead to less industry confusion and more consistent identification of “first generic” submissions.  
 
FDA believes that these proposed criteria appropriately focus FDA’s resources on approving new safe and effective generic drug products for patient use as quickly as possible,.  
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Teva Canada launches generic PrCelebrex

BY Ryan Chavis

TORONTO — Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex. The drug is indicated for symptomatic relief associated with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, according to the company. 
 
PrCelebrex had annual sales of $151 million in Canada as of September 2014, accoridng to IMS Brogan sales data. PrTeva-Celecoxib is available immediately in pharmacies across Canada.
 
"Arthritis is one of the most prevalent chronic conditions and the economic impact on the Canadian economy in healthcare costs and lost productivity is estimated by The Arthritis Society to be $33 billion each year," said Doug Sommerville, SVP and general manager, Teva Canada Limited. "Teva Canada is very pleased to be able to offer our more affordable, bioequivalent version of Celebrex to patients today. New generic launches in Canada over the last three years have saved patients and payers more than $2.3 billion versus the cost of the equivalent brand name drug product — and with today's launch, we are demonstrating our ongoing commitment to playing a critical role in ensuring the sustainability of the healthcare system."
 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?